<rss version="2.0"><channel><title>BioSpace.com News</title><link>http://www.biospace.com</link><generator>BioSpace RSS Generator</generator><lastBuildDate>Thu, 20 Jun 2013 05:45:35 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/BSPLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=1</link></image><copyright>Copyright (C) 2011</copyright><item><title>&lt;b&gt;R-Biopharm Rhone&lt;/b&gt; Supports Glasgow Caledonian Study Into Mycotoxins in Ethnic Shops  </title><link>http://www.biospace.com/news_story.aspx?StoryID=300214&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;June 17, 2013 -- The potential prevalence of deadly moulds in ethnic shops such as Chinese supermarkets is being investigated by Glasgow Caledonian University, backed by R-Biopharm Rhne, the manufacturer and...</description><pubDate>Mon, 17 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Mother's Age Tied to Risk of Delivery Complications, Trinity College Dublin Study  </title><link>http://www.reuters.com/article/2013/06/13/us-health-mothersage-delivery-idUSBRE95C19C20130613</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Teenage mothers are at increased risk of delivering their babies prematurely, while older moms are more likely to give birth via Caesarean section, according to a new study from Ireland.&lt;br&gt;&lt;br&gt;Help employers...</description><pubDate>Fri, 14 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Can Sunscreen Keep Your Skin From Aging? Queensland Institute of Medical Research Study  </title><link>http://www.forbes.com/sites/nextavenue/2013/06/11/can-sunscreen-keep-your-skin-from-aging/</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Sunscreen season has arrived, along with new guidelines for what actually constitutes defense from solar rays and new evidence that a daily slathering may not only protect you from skin cancer and sunburn, it...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Why Saliva of Adults Help Fight Bird Flu Better, &lt;i&gt;/i&gt;  Reveals  </title><link>http://www.scienceworldreport.com/articles/7483/20130613/saliva-protein-helps-older-people-fight-new-strains-bird-flu.htm</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Spit. Drool. Dribble. Saliva is not normally a topic of polite conversation, but it may be the key to explaining the age and sex bias exhibited by influenza and other diseases, according to a new study. Published...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Even Babies Prefer the Underdog, Kyoto University and Study  </title><link>http://www.scienceworldreport.com/articles/7486/20130613/ten-month-old-infants-use-non-verbal-ways-express-sympathy.htm</link><description>The human brain may be wired to sympathize with the underdog. Even if the underdog is a yellow square being chased by a blue circle, and the brain has been checking out the outside world for only 10 months.&lt;br&gt;&lt;br&gt;A Japanese research team found that 16 of 20 infants reached for the pursued yellow square rather than the aggressive blue ball as the ball bumped the square seven times, then smashed...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Better Athletes Have More Heart Arrhythmias, Uppsala University Hospital Study  </title><link>http://www.theatlantic.com/health/archive/2013/06/study-better-athletes-have-more-heart-arrhythmias/276768/</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;PROBLEM: Extreme endurance athletes, like long-distance runners, bikers, and even cross-country skiers, tend to have enlarged hearts. Also known as "Athlete's Heart," the condition may be associated with an...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Obese Women Risk Delivering Baby Early, Karolinska Institute Study  </title><link>http://www.telegraph.co.uk/journalists/laura-donnelly/10113736/Babies-put-at-risk-by-soaring-obesity.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Pregnant women who are overweight or obese are more likely to give birth prematurely, according to a new study from Sweden.&lt;br&gt;&lt;br&gt;Researchers found that link was strongest for babies born the earliest ...</description><pubDate>Wed, 12 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Gonorrhea Drug Resistance Recedes With New Drug Combo Approach, Lancet Study Reveals  </title><link>http://www.usnews.com/news/articles/2013/06/10/study-united-kingdom-staving-off-untreatable-gonorrhea-for-now</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Drug-resistant gonorrhea receded in the U.K. as doctors switched to a new combination of antibiotics to clear the sexually transmitted bacterium, a study found.&lt;br&gt;&lt;br&gt;Analysis of more than 6,000 samples...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>GlaxoSmithKline Probes Allegedly Fraudulent Data in Study Written by Employees  </title><link>http://www.pharmalive.com/glaxo-probes-allegedly-fraudulent-data-in-study-written-by-emplmoyees</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;In the latest instance in which a global drugmaker has become embroiled in a scandal over published study results, GlaxoSmithKline is investigating whether a paper that appeared in Nature Medicine three years...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Low Diastolic Pressure Linked to Brain Atrophy, University Medical Center Utrecht Study  </title><link>http://www.sciencedaily.com/releases/2013/06/130610192547.htm</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Low baseline diastolic blood pressure (DBP) appears to be associated with brain atrophy in patients with arterial disease, whenever declining levels of blood pressure (BP) over time among patients who had a...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Lack of Vitamin D Linked to Hypertension, University College London Study  </title><link>http://zeenews.india.com/news/health/diseases/lack-of-vitamin-d-linked-to-hypertension_22374.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;A large-scale genetic study involving over 155,000 individuals has enabled researchers to discover the causal link between hypertension and vitamin D deficiency. The results provide a strong case for food fortification...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Galderma Pharma S.A. Initiates Clinical Development of Novel Muscle Relaxant  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.b30484b92e958b11adda3242e6908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20130604006946&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;LAUSANNE, Switzerland--(BUSINESS WIRE)--Galderma today announced that it has initiated clinical development of a novel muscle relaxant, based on an advanced formulation of botulinum toxin, with the first cohort...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Retrogenix&lt;/b&gt; Points to New Drug Target for Malaria in Children  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299190&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;MANCHESTER, UK  5th June 2013  UK biotechnology company Retrogenix announces that its unique human cell microarray technology played a pivotal role in determining the molecular interaction that triggers severe...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Sapiens&lt;/b&gt; Reports Positive Preliminary Results From Intra-Operative Deep Brain Stimulation Study  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298239&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Munich, Germany, and Eindhoven, the Netherlands, May 29, 2013 - Sapiens Steering Brain Stimulation B.V. (Sapiens), an emerging medical device company developing brain stimulation products, today announced positive...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Oasmia???s Patented XR-17 Technology Generates Novel Cancer Combination Therapy  </title><link>http://www.globenewswire.com/news-release/2013/05/28/550099/0/en/Oasmia-s-patented-XR-17-technology-generates-novel-cancer-combination-therapy.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Uppsala, Sweden, 2013-05-28 14:00 CEST (GLOBE NEWSWIRE) -- Combination therapies are a standard treatment for a number of cancer diseases, such as breast cancer, prostate cancer and lung cancer. OAS-19 is the...</description><pubDate>Tue, 28 May 2013 12:00:00 AM GMT</pubDate></item><item><title>GlaxoSmithKline Flu Shot May Raise Adult Narcolepsy Risk  </title><link>http://www.reuters.com/article/2013/05/23/us-gsk-vaccine-narcolepsy-idUSBRE94M0FJ20130523</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health and Welfare said on Thursday...</description><pubDate>Thu, 23 May 2013 12:00:00 AM GMT</pubDate></item><item><title>TopoTarget A/S Release: Final Data From BELIEF Study for American Society of Clinical Oncology 2013 Confirms Objective Response Rate of 26%  </title><link>http://www.globenewswire.com/news-release/2013/05/16/547616/0/en/Final-data-from-BELIEF-study-for-ASCO-2013-confirms-objective-response-rate-of-26.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Topotarget announces that an abstract containing positive final data from the registrational BELIEF study with belinostat in peripheral T-cell lymphoma (PTCL) has been released for presentation on ASCO (American...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>MorphoSys AG Announces First Scientific Publication on  Novel Antibody Platform Ylanthia  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296279&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;MARTINSRIED, GERMANY and MUNICH, GERMANY--(Marketwired - May       10, 2013) -   MorphoSys  AG(FSE: MOR; Prime Standard  Segment; TecDAX) announced today that afirst  scientific...</description><pubDate>Fri, 10 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Pluristem Therapeutics Develops PLX-RAD Cells for Use in Hematology  </title><link>http://www.globenewswire.com/news-release/2013/05/07/544899/10031706/en/Pluristem-Develops-PLX-RAD-Cells-for-Use-in-Hematology.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;HAIFA, Israel, May 7, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that it has identified its first clinical...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Oasmia Initiates Clinical Program With Paclical&amp;#0174; in Metastatic Breast Cancer  </title><link>http://www.globenewswire.com/news-release/2013/05/06/544597/0/en/Oasmia-initiates-clinical-program-with-Paclical-in-metastatic-breast-cancer.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Uppsala, Sweden, 2013-05-06 14:00 CEST (GLOBE NEWSWIRE) --  The active substance of Paclical, paclitaxel, is used in the treatment of breast cancer, often in combination with e.g. hormonal treatment. Cytostatic...</description><pubDate>Mon, 06 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Procarta Biosystems&lt;/b&gt; Release: Fight Back Against MRSA to be Started With a Sniff  </title><link>http://www.biospace.com/news_story.aspx?StoryID=291514&amp;full=1</link><description>March 25, 2013 -- An innovative anti-bacterial spray that will kill just MRSA is being developed by Norwich Research Park scientists. The spray, which can be used in the nose to decolonise patients prior to major surgery, promises to speed recovery time and reduce the number of repeat operations.  &lt;/p&gt;&lt;p&gt;Procarta Biosystems has developed a novel type of antibiotic specifically to treat MRSA and...</description><pubDate>Mon, 25 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Important Find by Genome Institute of Singapore Scientists Shows How Gene Regulators Select Different Partners to Form Different Organs  </title><link>http://www.biospace.com/news_story.aspx?StoryID=290581&amp;full=1</link><description>14 March 2013 -- Scientists at the Agency for Science, Technology and Researchs (A*STAR) Genome Institute of Singapore (GIS) have discovered that key gene regulators work in pairs to trigger stem cells to differentiate into specific cell types. Furthermore, they showed that selective partnering of the regulators result in uniquely specified developmental outcomes.&lt;/p&gt;&lt;p&gt;An embryo develops from...</description><pubDate>Thu, 14 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Boehringer Ingelheim Corporation Release: Pharmaco-Invasive Strategy Including Metalyse&amp;#0174; Delivers Comparable Clinical Outcomes to Primary PCI for STEMI Patients Who Could Not Undergo Primary PCI Within One Hour From First Medical Contact  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20130311005518&amp;newsLang=en</link><description>INGELHEIM, Germany--(BUSINESS WIRE)--  New data presented at the American College of Cardiology 62nd Annual Scientific Sessions and Expo demonstrate that patients with ST elevation acute myocardial infarction (STEMI), who cannot undergo primary percutaneous intervention (PCI) in a catheterization lab within 60 minutes of first medical contact, have similar clinical outcomes from early fibrinolysis...</description><pubDate>Mon, 11 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Activartis Biotech GmbH Receives Orphan Drug Designation for It's Cancer Immune Therapy AV0113  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289848&amp;full=1</link><description>Vienna, Austria, March 7, 2013 / B3C newswire / - The European Medicines Agency recently awarded the Austrian biotech company Activartis an Orphan Drug Designation for its innovative Cancer Immune Therapy AV0113. The Orphan Drug Designation applies specifically to the use of AV0113 for the treatment of glioma, a type of brain tumour, which afflicts around one in 10.000 people in the EU. The term Orphan...</description><pubDate>Thu, 07 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Verona Pharma Release: RPL554 Demonstrates Airway Anti-Inflammatory Activity  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289520&amp;full=1</link><description>March 05, 2013 -- Verona Pharma plc (VRP: London Stock Exchange) (Verona Pharma, or the Company), the biotechnology company focused on developing novel treatments for chronic respiratory diseases today announces the results of an exploratory, placebo-controlled, double-blind clinical trial designed to specifically evaluate the anti-inflammatory properties of RPL554 in healthy subjects challenged...</description><pubDate>Tue, 05 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Marinomed Biotechnologie GmbH's Antiviral Spray Fights Cold in Canada  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289529&amp;full=1</link><description>Vienna, March 5, 2013 - An innovative nasal spray that has been proven clinically effective against respiratory viruses has now been authorized for the Canadian market. The product, which was developed by the Viennese biotech company Marinomed, reduces the reproduction and spread of viruses on the nasal mucosa and is based on Marinomed's proprietary technology platform Mavirex. This platform exploits...</description><pubDate>Tue, 05 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>APEIRON Biologics AG Release: Success in Avoiding Radiation Skin Damage for Breast Cancer Patients  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289536&amp;full=1</link><description>Vienna, 5 March 2013 - APEIRON Biologics AG (Apeiron) today announced that the clinical trial with their liposomal formulation of recombinant superoxide dismutase (project APN201) which started in March 2012 concluded with positive outcomes in all endpoints analyzed.&lt;/p&gt;&lt;p&gt;Today, Apeiron announced that the clinical trial with APN201 (a liposomal formulation of human recombinant superoxide dismutase...</description><pubDate>Tue, 05 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>InnaVirVax Announces Publication of an Article in  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289215&amp;full=1</link><description>Evry, 1st March 2013  InnaVirVax, a biopharmaceutical company specialised in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, today announced the publication of a new scientific article in the prestigious journal JAIDS (Journal of Acquired Immune Deficiency Syndromes) (http://journals.lww.com/jaids/toc/2012/11010).&lt;/p&gt;&lt;p&gt;Although it is known...</description><pubDate>Fri, 01 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>??993,000 ($1.5 Million) Challenge Funding Awarded to Develop Animal Research Alternatives and Refinements  </title><link>http://www.biospace.com/news_story.aspx?StoryID=287608&amp;full=1</link><description>13th January 2013 -- The CRACK IT open-innovation platform has awarded 993,000 to 11 challenge finalists who have been given just six months to develop the most successful proof-of-concepts for five business and technology challenges in preclinical research.&lt;/p&gt;&lt;p&gt;The platform primarily contributes to funding replacement, reduction and refinement (3Rs) in the use of animals in research and testing...</description><pubDate>Wed, 13 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Brainsway Announces Final Results in Clinical Trial for Smoking Cessation in Chronic Obstructive Pulmonary Disease Patients  </title><link>http://www.globenewswire.com/news-release/2013/01/24/518417/10019282/en/Brainsway-Announces-Final-Results-in-Clinical-Trial-for-Smoking-Cessation-in-Chronic-Obstructive-Pulmonary-Disease-Patients.html</link><description>JERUSALEM, Jan. 24, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company) is pleased to announce that it has received final results with respect to a clinical trial that was conducted at the Be'er Ya'akov Mental Health Center to assess the efficacy of the Company's Deep TMS device in inducing smoking cessation in chronic obstructive pulmonary disease ("COPD") patients using...</description><pubDate>Fri, 25 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Roche Scientists Uncover Unexpected Enzyme Activity in HCV RNA Polymerase  </title><link>http://www.biospace.com/news_story.aspx?StoryID=284515&amp;full=1</link><description>NUTLEY, NJ  January 10, 2013  Today, Roche scientists detail the discovery of a new enzyme activity that allows HCV polymerase to remove nucleosides and nucleoside analogues from RNA molecules, which could have implications for future hepatitis C (HCV) drug development. In findings, presented online in the January 10th Early Edition issue of Proceedings of the National Academy of Science...</description><pubDate>Fri, 11 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>High CRP Levels May Up Risk of Depression, Psychological Distress, Copenhagen University Hospital Study  </title><link>http://www.sciencedaily.com/releases/2012/12/121226081050.htm</link><description>Elevated levels of C-reactive protein, a marker of inflammatory disease, appear to be associated with increased risk of psychological distress and depression in the general population of adults in Denmark, according to a report published Online First by Archives of General Psychiatry, a JAMA Network publication.</description><pubDate>Thu, 27 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;PledPharma&lt;/b&gt; Release: New Study Shows Superior Ability of PledOx to Reduce Chemotherapy Side Effects  </title><link>http://www.globenewswire.com/news-release/2012/12/27/513671/0/en/New-Study-Shows-Superior-Ability-of-PledOx-to-Reduce-Chemotherapy-Side-Effects.html</link><description>Stockholm, 2012-12-27 12:16 CET (GLOBE NEWSWIRE) -- Colorectal cancer is the third most common cancer-related cause of death in the Western world.  A standard treatment in this disease is oxaliplatin-based chemotherapy. However, serious side effects in more than half of the patients lead to an intolerable burden and cause dose reductions, delays, or, in worst-case scenarios, complete discontinuation...</description><pubDate>Thu, 27 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Biohit Announces Results From Acetaldehyde Measurements  </title><link>http://www.globenewswire.com/news-release/2012/12/20/512843/0/en/Biohit-announces-results-from-acetaldehyde-measurements.html</link><description>Biohit has carried out measurements of carcinogenic acetaldehyde concentrations in foodstuff. Acetaldehyde is a widely used and naturally occurring group-1 carcinogen with apple scent. Industry produces hundreds of thousands of tons it annually. Acetaldehyde is especially rich in food prepared with a fermentation process such as alcohol beverages, vinegar and dairy products.</description><pubDate>Thu, 20 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;PledPharma&lt;/b&gt; Broadens Patient Base for the PLIANT Study  </title><link>http://www.globenewswire.com/news-release/2012/12/19/512454/0/en/PledPharma-Broadens-Patient-Base-for-the-PLIANT-Study.html</link><description>Stockholm, 2012-12-19 08:30 CET (GLOBE NEWSWIRE) -- Colorectal cancer is the third most common cancer-related cause of death in the Western world. Standard treatment for metastatic colorectal cancer is the chemotherapy FOLFOX but serious side effects lead to that less than half of the patients receive the recommended dose, and thus are unlikely to fully benefit from the treatment.</description><pubDate>Wed, 19 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Almac Discovery Announces Selection of Preclinical Development Candidate for Its Allosteric Akt Inhibitor Programme.  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20121217005759&amp;newsLang=en</link><description>CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac Discovery is pleased to announce the selection of a preclinical development candidate from its allosteric Akt inhibitor programme. Akt is a key component of the PI3K pathway, one of the major pathways driving tumour growth in many cancer types. ALM301 is a potent, subtype selective Akt1 &amp; Akt2 inhibitor with good pharmacokinetic properties in multiple...</description><pubDate>Mon, 17 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Aerocrine: UK Clinical Study Demonstrates That Asthma Tests Can Identify Non-Adherence to Medication  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20121216005055&amp;newsLang=en</link><description>SOLNA, Sweden--(BUSINESS WIRE)--Aerocrine AB (OMX Nordic Exchange: AERO) announces that a clinical trial published in The American Journal of Respiratory and Critical Care Medicine shows that FeNO-testing is an excellent tool to identify patients that dont adhere to treatment. The American Journal of Respiratory and Critical Care Medicine published on December 1, 2012, the results of a clinical study...</description><pubDate>Mon, 17 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Major Breakthrough in HIV Research: and Study Published Today Online in /i&gt; Identifies Population of Cells Serving as the Major Reservoir for HIV  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20121217005466&amp;newsLang=en</link><description>LAUSANNE, Switzerland--(BUSINESS WIRE)--A study published today online in The Journal of Experimental Medicine has identified the population of CD4 T cells serving as the major reservoir for HIV infected cells and as the primary cell site for HIV replication and production in infected patients. The study was led by Prof. Giuseppe Pantaleo and Dr. Matthieu Perreau at the Division of Immunology and Allergy...</description><pubDate>Mon, 17 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Genmab A/S Unveils A New Antibody Technology Platform: HexaBody  </title><link>http://www.globenewswire.com/news-release/2012/12/17/511834/0/en/Genmab-Unveils-A-New-Antibody-Technology-Platform-HexaBody.html</link><description>Copenhagen, Denmark; December 17, 2012  Genmab A/S (OMX: GEN) announced today the addition of a new proprietary technology, the HexaBody platform, to its suite of next generation antibody technologies.  The HexaBody platform is a novel technology that allows the creation of differentiated antibody therapeutics by enhancing the natural target killing abilities of antibodies in a fundamentally new...</description><pubDate>Mon, 17 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Conformetrix&lt;/b&gt; Announces Details of Lead Proprietary Program Company Investigating Selective Orexin-1 Receptor Inhibitors  </title><link>http://www.biospace.com/news_story.aspx?StoryID=282554&amp;full=1</link><description>Manchester, UK,  December  17  2012    Conformetrix Ltd, a leader in optimising drug discovery and design,  is pleased to announce progress in  its  lead proprietary programme, focused on  selective  inhibition of  the  orexin-1  receptor  (OX1R). The company has generated a series of  potent  antagonists, which it plans to evaluate and progress to drug leads. Orexin is a neurotransmitter...</description><pubDate>Thu, 13 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Reconstruction of Prehistoric DNA Refutes Criticism on Theory of Evolution, VIB,  Ghent University, Harvard University Study  </title><link>http://www.biospace.com/news_story.aspx?StoryID=281845&amp;full=1</link><description>December 10, 2012 -- Scientists from VIB, KU Leuven, UGent and Harvard have succeeded in reconstructing DNA and proteins from prehistoric yeast cells. This made it possible to determine how genes developed and evolved into their current form over more than 100 million years. &lt;/p&gt;&lt;p&gt;Kevin Verstrepen (VIB/KU Leuven): These results provide answers to an argument frequently used by opponents of the...</description><pubDate>Mon, 10 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>PolyPid Ltd. Announces Positive Preliminary Results of Clinical Trial With BonyPid&amp;#0153; - Revolutionary Product for Treatment of Contaminated/Infected Severe Open Bone Fractures  </title><link>http://www.biospace.com/news_story.aspx?StoryID=281854&amp;full=1</link><description>Petach Tikva, Israel, December 10, 2012. PolyPid Ltd., a biotechnology company and developer of the PolyPid drug delivery nanotechnology platform, announced today positive preliminary results of a first-in-man clinical trial with its BonyPid product. In the study, BonyPid demonstrated a clear, positive signal of effect in bone recovery processes, following its early implantation onto the bone void...</description><pubDate>Mon, 10 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Norwich Research Park&lt;/b&gt; Under-the-Tongue Spray Could Cut Child Malaria Deaths  </title><link>http://www.biospace.com/news_story.aspx?StoryID=281402&amp;full=1</link><description>December 05, 2012 -- Malaria kills an African child every 30 seconds, many of whom die because they were unable to reach a hospital in time. A new under-the-tongue spray developed by Norwich Research Park company LondonPharma could help cut deaths by helping children recover sufficiently to survive the journey to hospital.&lt;/p&gt;&lt;p&gt;LondonPharma, recently voted Best Emerging Biotech of the Year...</description><pubDate>Wed, 05 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Baidu-I2R Research Center&lt;/b&gt; (&lt;b&gt;BIRC&lt;/b&gt;) Brings First Speaker Verification Technology Into Smartphones With Built-In Voiceprint Feature  </title><link>http://www.biospace.com/news_story.aspx?StoryID=281042&amp;full=1</link><description>Singapore, 30 November 2012 -    1.   Using your voice as a unique identification to unlock your smartphone is no longer a fantasy or just another scene from a futuristic movie. The technology will be embedded in Lenovos smartphone - Lenovo A586, which will be available from 30th November 2012 in China through major telecommunications providers and online shops. This innovative Speaker Verification...</description><pubDate>Fri, 30 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Results Fom Clinical Studies in Immune and Gut Health  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20121128006503&amp;newsLang=en</link><description>LUND, Sweden--(BUSINESS WIRE)--Regulatory News: The results from Probis (STO:PROB) two clinical studies conducted in 2012, one in immune health and one in gut health, are now available. Preliminary analyses of the data show that the results from the studies did not meet expectations. Probi will consequently not apply to the European Food Safety Authority (EFSA) for health claims within the EU at this...</description><pubDate>Thu, 29 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>A*STAR Scientists Identify Potential Drug Target for Inflammatory Diseases Including Cancers  </title><link>http://www.biospace.com/news_story.aspx?StoryID=280450&amp;full=1</link><description>November 21, 2012 -- 1.            A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized as a key underlying cause for the development of many human cancers, autoimmune disorders, neurodegenerative diseases, and metabolic diseases such as diabetes. This enzyme, which is known to be responsible for providing...</description><pubDate>Wed, 21 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>News for Men: Size Matters When it Comes to Your Swimmers, University of Sheffield Study  </title><link>http://www.forbes.com/sites/daviddisalvo/2012/11/14/news-for-men-size-matters-when-it-comes-to-your-swimmers/</link><description>If you were to survey a random group of men about their greatest health concerns, I doubt the length of their sperm cells would even make the list.  But thanks to new research published in the journal  Human Reproduction, guys with fertility on their minds can add sperm size to their docket of worries.</description><pubDate>Mon, 19 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Fetus Suffers When Mother Lacks Vitamin C, University of Copenhagen Study  </title><link>http://www.bestsyndication.com/?q=20121115_vitamin_c_deficiency_pregnancy_brain_damage_for_baby.htm</link><description>Maternal vitamin C deficiency during pregnancy can have serious consequences for the foetal brain. And once brain damage has occurred, it cannot be reversed by vitamin C supplements after birth. This is shown through new research at the University of Copenhagen just published in the scientific journal PLOS ONE.</description><pubDate>Fri, 16 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Oxytocin Keeps Attached Men Away From Hot Women, University of Bonn Study  </title><link>http://www.sciencecodex.com/hormone_affects_distance_men_keep_from_unknown_women_they_find_attractive-102023</link><description>Men in committed relationships choose to keep a greater distance between themselves and an unknown woman they find attractive when given the hormone oxytocin, according to new research in the November 14 issue of The Journal of Neuroscience. The findings suggest oxytocin may help promote fidelity within monogamous relationships.</description><pubDate>Fri, 16 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>New Gene Triples Risk for Alzheimer's Disease, deCODE genetics, Inc. and University College London Study  </title><link>http://www.nytimes.com/2012/11/15/health/gene-mutation-that-hobbles-immune-response-is-linked-to-alzheimers.html?_r=0</link><description>Two international teams of scientists have identified a rare mutation in a gene linked with inflammation that significantly increases the risk for the most common form of Alzheimer's disease, the first such discovery in at least a decade.&lt;br&gt;&lt;br&gt;The findings, published on Wednesday in the New England Journal of Medicine, offer new insights into the underpinnings of Alzheimer's, a deadly, brain...</description><pubDate>Thu, 15 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Light Drinking While Pregnant Could Lower Baby's IQ, University of Oxford Study  </title><link>http://www.reuters.com/article/2012/11/14/alcohol-pregnancy-idUSL5E8ME35O20121114</link><description>Bad news for moms-to-be: Drinking even a few alcoholic beverages per week during pregnancy could lower a baby's IQ by a few points, a new study has found.&lt;br&gt;&lt;br&gt;The findings, published Nov. 14 in the journal PLoS ONE, also suggest that women whose bodies process alcohol slowly are at greater risk of harming their baby's brain development.</description><pubDate>Thu, 15 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Sudden Cardiac Death Risk May Be Family Matter, Statens Serum Institut (SSI) Study  </title><link>http://www.everydayhealth.com/heart-health/1113/relatives-of-sudden-cardiac-death-victims-need-heart-disease-screenings.aspx</link><description>Relatives of young people who have died suddenly from a heart-related problem are at greatly increased risk of developing cardiovascular disease according to a study published online today (Wednesday) in the European Heart Journal.</description><pubDate>Wed, 14 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Migraines Linked to Brain Lesions in Women, Leiden University Medical Center Study  </title><link>http://www.webmd.com/migraines-headaches/news/20121108/migraines-brain-changes-not-linked-to-mental-harm</link><description>Women with migraines are more likely to have a larger increase of deep white matter hyperintensities (brian lesions) than females without migraines. However, the frequency, number, and severity of migraines are not associated with the progression of the lesions.</description><pubDate>Wed, 14 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>DNA Sequencing of MRSA Used to Stop Outbreak, Cambridge University and Sanger Institute Study  </title><link>http://www.dailymail.co.uk/health/article-2232720/Doctors-stop-hospital-outbreak-MRSA-cracking-genetic-code-tracking-health-care-worker-carrying-bacteria.html?ITO=1490&amp;ns_mchannel=rss&amp;ns_campaign=1490</link><description>An outbreak of the hospital superbug MRSA has been brought to an end by UK doctors cracking the bacterium's genetic code.&lt;br&gt;&lt;br&gt;It led to them finding one member of staff at Rosie Hospital, in Cambridge, who may have unwittingly carried and spread the infection.&lt;br&gt;&lt;br&gt;They say it is the first time rapid genetic testing has been used to track and then stop an outbreak.</description><pubDate>Wed, 14 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Brainsway Announces Breakthrough Results in Clinical Trials in Parkinson's, Migraine and More  </title><link>http://www.globenewswire.com/news-release/2012/11/13/504826/10012364/en/Brainsway-Announces-Breakthrough-Results-in-Clinical-Trials-in-Parkinson-s-Migraine-and-More.html</link><description>JERUSALEM, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Further to Brainsway's (TASE:BRIN) announcement regarding the association between Brainsway and Advanced Technologies Innovation Distribution SRL ("ATID") for the marketing and sales promotion of Brainsway's Deep TMS devices in Italy, in the context of which ATID has been conducting - among its other activities - clinical trials in the San Raffaele medical...</description><pubDate>Wed, 14 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Brainsway Release: Multiple Sclerosis Clinical Trial - Final Results  </title><link>http://www.globenewswire.com/news-release/2012/11/13/504882/10012433/en/Multiple-Sclerosis-Clinical-Trial-Final-Results.html</link><description>JERUSALEM, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Further to that stated in Brainsway's (TASE:BRIN) periodic report for 2011 regarding the double-blind clinical trial being conducted at the Charit Hospital in Berlin and at the University Medical Center Hamburg-Eppendorf in Hamburg to assess the safety and efficacy of the Company's Deep TMS device for the treatment of fatigue and depression symptoms in...</description><pubDate>Wed, 14 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Has Your Friend Got an Itch? You Might Too, and Study  </title><link>http://www.telegraph.co.uk/science/science-news/9673006/Itching-more-contagious-among-nervous-people.html</link><description>Have you ever experienced the feelings of itchiness while watching someone else scratch? Scientists University of Sussex and the University of Hull have found the part of the brain responsible for 'contagious' itching  and discovered why some people are more prone to it than others.</description><pubDate>Tue, 13 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Bone Medication May Save Knees, University of Liege Study  </title><link>http://www.webmd.com/pain-management/knee-pain/news/20121108/drug-slows-knee-osteoarthritis</link><description>According to research presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C., a daily dose of strontium ranelate -- a medication prescribed for osteoporosis -- may delay knee osteoarthritis progression. The study also revealed that taking strontium ranelate may improve knee pain, reduce joint damage and the need for surgery.</description><pubDate>Tue, 13 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Can-Fite BioPharma to Develop a Drug for the Treatment of Sexual Dysfunction  </title><link>http://www.biospace.com/news_story.aspx?StoryID=279612&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p /&gt;&lt;p&gt;PETACH TIKVA, &lt;span class"xn-location"&gt;Israel&lt;/span&gt;, &lt;span class"xn-chron"&gt;Nov. 13, 2012&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;Can-Fite BioPharma (TASE: CFBI, OTC: CANFY)&lt;/b&gt;, a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it designated the CF602 drug, which was licensed from the...</description><pubDate>Tue, 13 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Breakthrough Chemo Bath Treats Liver Cancer for First Time in UK, Reveals  </title><link>http://www.medicalnewstoday.com/articles/252669.php</link><description>A treatment that isolates the blood supply to a cancerous liver while the organ receives a "chemo bath" has been used for the first time in the UK. The procedure saturates the liver with high doses of chemotherapy without affecting the rest of the body.&lt;br&gt;&lt;br&gt;This week, various media have reported how Brian Stedman, a consultant interventional radiologist at Southampton General Hospital, used...</description><pubDate>Mon, 12 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Acetaminophen in Infancy Again Tied to Asthma: University of Copenhagen Study  </title><link>http://www.straitstimes.com/breaking-news/technology/story/acetaminophen-infancy-again-tied-asthma-study-20121112</link><description>Babies given acetaminophen for fevers and aches may have a heightened risk of asthma symptoms in their preschool years, according to a Danish study.&lt;br&gt;&lt;br&gt;The findings, published in the Journal of Allergy and Clinical Immunology, focused on 411 Danish children and add to a mixed bag of research about whether there's a link between acetaminophen - better known by the brand name Tylenol - and children...</description><pubDate>Mon, 12 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Asthma Linked to Genetics, American College of Allergy, Asthma and Immunology (ACAAI) Reveals  </title><link>http://www.medicalnewstoday.com/releases/252624.php</link><description>African American males are among those at greatest risk for severe asthma attacks. In a new study presented at the American College of Allergy, Asthma and Immunology's (ACAAI) Annual Scientific Meeting in Anaheim, Calif. Nov. 8-13, researchers assessed the relationship between genetic ancestry and severe asthma. It was concluded that African ancestry was significantly associated with severe asthma...</description><pubDate>Mon, 12 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Flu During Pregnancy Linked to Autism, Study  </title><link>http://www.webmd.com/brain/autism/news/20121109/flu-pregnancy-autism?src=RSS_PUBLIC</link><description>Kids whose mothers had the flu while pregnant were slightly more likely to be diagnosed with "infantile autism" before age three in a new Danish study. But the children's overall risk for the developmental disorder was not higher than that of other kids.&lt;br&gt;&lt;br&gt;Researchers said it's possible that activation of a mother's immune system - such as by infection with the influenza virus - could affect...</description><pubDate>Mon, 12 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Domainex Ltd Researchers Identify Small-Molecule Inhibitors of TBK1/IKKepsilon Affecting IL-17 Signaling  </title><link>http://www.biospace.com/news_story.aspx?StoryID=278369&amp;full=1</link><description>Cambridge, UK, November 5, 2012 / B3C newswire / - Domainex Ltd., a UK-based drug discovery company, has developed a number of chemical series with potent and selective activity against two closely-related kinases TBK1 and IKKepsilon. IL-17 mediated signaling is known to induce the expression of cytokines and other effectors that can cause a variety of immunological diseases such as psoriasis and Chronic...</description><pubDate>Mon, 05 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Sanofi (France) Worm Pill Kills Resistant Head Lice as a Lotion  </title><link>http://www.bloomberg.com/news/2012-10-31/sanofi-worm-pill-kills-resistant-head-lice-as-a-lotion.html</link><description>Sanofi (SAN)s lotion Sklice, which as a tablet treated worms, wiped out head lice in a single application in a study that suggests the drug may offer a better approach than existing medications, researchers said.&lt;br&gt;&lt;br&gt;A day after treatment, 95 percent of those in the Sklice group were lice free compared with 31 percent given a placebo, according to company funded-studies that helped gain the...</description><pubDate>Thu, 01 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>Towards a Better Treatment for Head and Neck Cancers? Western Australian Institute for Medical Research Study Reveals  </title><link>http://www.biospace.com/news_story.aspx?StoryID=277276&amp;full=1</link><description>25th October 2012 -- Researchers from the Western Australian Institute for Medical Research (WAIMR) have taken an important step towards improved treatment of head and neck cancers with new work that has been published by the journal PLOS ONE. &lt;/p&gt;&lt;p&gt;The researchers, led by Professor Peter Leedman, conducted an in vitro study to explore a potential synergy between a tiny RNA molecule, miR-7, and...</description><pubDate>Thu, 25 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Shire Pharmaceuticals Release: International Study Reveals Disconnect Between Patients and Healthcare Professionals (HCPS) Over Symptom Burden in Ulcerative Colitis (UC)  </title><link>http://www.biospace.com/news_story.aspx?StoryID=276836&amp;full=1</link><description>Amsterdam, 22 October 2012  The results of an international survey to assess patients and healthcare professionals (HCPs) differing perceptions of ulcerative colitis have been presented  at a Shire organised press briefing  during  the 20th United European Gastroenterology Week (UEGW) meeting in Amsterdam today. The Mind the Gap survey, which was sponsored by Shire, is the first international...</description><pubDate>Mon, 22 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;AdiStem&lt;/b&gt; Announces PhotoActivated PRP Getting Superb Results on Joint Pain  </title><link>http://www.biospace.com/news_story.aspx?StoryID=275403&amp;full=1</link><description>Melbourne, Australia, October 8, 2012 / B3C newswire / - AdiStem Ltd., a provider of PhotoActivation Technology and medical solutions that assist in orthopedic, cosmetic, neurologic, pulmonary, metabolic and plastic/reconstructive surgery procedures, announces today that photoactivated PRP (Platelet Rich Plasma) prior to injection reduces pain and accelerates healing. &lt;/p&gt;&lt;p&gt;PRP injections have...</description><pubDate>Mon, 08 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>New Function of a Protein Involved in Colon Cancer is Identified, Study  </title><link>http://www.sciencedaily.com/releases/2012/10/121004121554.htm</link><description>Researchers from IMIM, Hospital del Mar Medical Research Institute, have succeeded in determining the function of a new variant of enzyme IKKalpha (IKKa) to activate some of the genes taking part in the tumor progressions of colorectal cancer. In the future, this fact will make it possible to design new drugs that inhibit this enzyme specifically and are less toxic for the remaining body cells, hence...</description><pubDate>Fri, 05 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Cellectis Publishes Results Paving the Way for New Therapeutic Approaches Against Cancer and Genetic Diseases  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20121002006411&amp;newsLang=en</link><description>PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Alternext: ALCLS), the French genome engineering specialist, announces in the Journal of Biological Chemistry, one of the most respected scientific journals in the world, the publication of a new approach regarding the targeted modification of DNA2. The manuscript unmasks novel perspectives and broadens the scope of TALENsTM technology to new therapeutic...</description><pubDate>Tue, 02 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Probiotic for Babies May Not Fight Allergies Later, University of Western Australia Study Reveals  </title><link>http://in.reuters.com/article/2012/09/28/us-probiotic-for-babies-idINBRE88R13Q20120928</link><description>Kindergartners who were given "good bacteria" supplements as infants were no less likely to suffer from allergies than other kids in a new study from Australia. The findings, reported in the Journal of Allergy and Clinical Immunology, add to a mixed bag of results from research into whether probiotics can help ward off kids' allergies. Based on what's known so far, it may be that only certain probiotics...</description><pubDate>Fri, 28 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>Diabetes Drug Could Help Fight Alzheimer's Disease, Study  </title><link>http://zeenews.india.com/news/health/diseases/diabetes-drug-could-help-fight-alzheimers_18859.html</link><description>A drug designed for diabetes sufferers could have the potential to treat neurodegenerative diseases like Alzheimer's, a study by scientists at the University of Ulster has revealed. Type II diabetes is a known risk factor for Alzheimer's and it is thought that impaired insulin signalling in the brain could damage nerve cells and contribute to the disease. Scientists believe that drugs designed to tackle...</description><pubDate>Tue, 18 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;BioGaia AB&lt;/b&gt;: Lactobacillus Reuteri Protectis Shown to Reduce Colic in Infants  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20120917005928&amp;newsLang=en</link><description>STOCKHOLM--(BUSINESS WIRE)--Regulatory News: A double-blind, placebo-controlled study of 80 colicky infants showed that the crying time was significantly reduced among the infants supplemented by drops with the probiotic Lactobacillus reuteri Protectis compared to those in the placebo group. The quality of life for the parents and families were also significantly improved in the probiotic group compared...</description><pubDate>Mon, 17 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;GlobalData&lt;/b&gt; Release: Gene Suppression Significantly Prolongs Life in ALS: Potential for Future Blockbuster Treatment?  </title><link>http://www.biospace.com/news_story.aspx?StoryID=272097&amp;full=1</link><description>LONDON, UK (GlobalData), 5 September 2012  - Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrigs disease, is a fatal, rapidly progressive neurodegenerative disorder characterized by weakness, muscle atrophy and spasticity due to the selective loss of both upper and lower motor neurons.  ALS is the most common motor neuron disease, affecting more than 86,000 people worldwide, and with an...</description><pubDate>Wed, 05 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>Chocolate May Protect the Brain From Stroke, Karolinska Institute Study  </title><link>http://www.sciencedaily.com/releases/2012/08/120829171933.htm</link><description>Chocolate might not be the healthiest thing for your waistline - but research suggests it may protect against stroke. A study following more than 37,000 Swedish men showed those eating the most chocolate were the least likely to have a stroke.It follows on from other studies that have suggested eating chocolate can improve the health of the heart.</description><pubDate>Fri, 31 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>Boehringer Ingelheim Corporation Release: Large Scale Registry Shows Atrial Fibrillation Management is Suboptimal and Unequal Around the World  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20120829005530&amp;newsLang=en</link><description>MUNICH--(BUSINESS WIRE)-- New one-year follow-up results from the global RE-LY AF registry, a multinational primary care registry, have been announced for the first time during the European Society of Cardiology (ESC) Congress 2012. The findings show that 11.7% of patients with atrial fibrillation (AF) who were included in the registry from January 2008 to April 2011 had died within one year.1 The...</description><pubDate>Wed, 29 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>Almac Group Streamline Temperature Sensitive Clinical Supplies With Enhanced Service Offering  </title><link>http://www.biospace.com/news_story.aspx?StoryID=269431&amp;full=1</link><description>8 August 2012 -- Almac, leading experts in the management of temperature controlled clinical supplies, has further enhanced its service offering with the completed expansion of refrigerated (2-8C) storage and newly developed refrigerated labelling facilities at its UK site.  This enhancement doubles Almacs refrigerated storage capacity at its UK site and comes as a response to a growing number of...</description><pubDate>Thu, 09 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>Scientists Discover Possible Antibiotics Alternative, Monash University Study  </title><link>http://www.smh.com.au/national/health/new-protein-could-rival-antibiotics-20120728-232uo.html</link><description>Researchers from Monash University in Melbourne, along with The Rockfeller University and the University of Maryland in the United States, have spent the past six years studying the structure of a viral protein called PlyC. They say they have discovered the way it kills the bacteria that causes a range of infections including sore throats, pneumonia and streptococcal toxic shock syndrome. They have...</description><pubDate>Tue, 31 Jul 2012 12:00:00 AM GMT</pubDate></item><item><title>Alcohol Can Triple Original Dose of Medicine, Monash University Reveals  </title><link>http://zeenews.india.com/news/health/health-news/why-you-should-avoid-alcohol-while-on-medication_18088.html</link><description>Always avoid alcohol while taking certain medicines because it actually triples the original dose, warn researchers. Lab experiments have demonstrated how alcohol made several drugs up to three times more available to the body, effectively tripling the original dose, said Christel Bergstrom, associate professor of pharmacology at Monash University, who led the study.</description><pubDate>Mon, 30 Jul 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;ClinTec International&lt;/b&gt;, Leading Global CRO in the Middle East and Africa, Starts Operations in Malawi and Strengthens Its Expertise in Vaccine Development  </title><link>http://www.biospace.com/news_story.aspx?StoryID=268159&amp;full=1</link><description>July 30, 2012 -- ClinTec International, a leading global CRO with a substantial presence in the Middle East and Africa has expanded its operations into Malawi, appointing its first highly experienced clinical research associates.  A top 5 pharmaceutical company with sales exceeding US$50 billion has selected ClinTec as its preferred partner for vaccine development in Africa and Asia, further enhancing...</description><pubDate>Mon, 30 Jul 2012 12:00:00 AM GMT</pubDate></item></channel></rss>